News Image

Exploring NYSE:CHE's quality characteristics.

By Mill Chart

Last update: Oct 31, 2023

In this article we will dive into CHEMED CORP (NYSE:CHE) as a possible candidate for quality investing. Investors should always do their own research, but we noticed CHEMED CORP showing up in our Caviar Cruise quality screen, which makes it worth to investigate a bit more.

Looking into the quality metrics of CHEMED CORP

  • CHEMED CORP has achieved substantial revenue growth over the past 5 years, with a 5.08% increase. This signifies the company's ability to successfully capture market opportunities and generate sustained revenue growth.
  • With a robust ROIC excluding cash and goodwill at 58.91%, CHEMED CORP showcases its effective allocation of capital and operational excellence. This metric signifies the company's ability to generate attractive returns and supports its long-term financial performance.
  • With a favorable Debt/Free Cash Flow Ratio of 0.06, CHEMED CORP showcases its sound financial discipline and cash flow management. This ratio indicates the company's ability to service its debt obligations while maintaining sufficient free cash flow for future investments or operational needs.
  • The Profit Quality (5-year) of CHEMED CORP stands at 111.0%, highlighting its ability to consistently generate reliable profits. This metric underscores the company's strong business fundamentals and reinforces its position as a financially stable entity.
  • CHEMED CORP has consistently achieved strong EBIT growth over the past 5 years, with a 9.79% increase. This underscores the company's effective management of its operating income and suggests a positive outlook for future profitability.
  • CHEMED CORP demonstrates a remarkable trend where its EBIT 5-year growth exceeds its Revenue 5-year growth. This indicates the company's ability to enhance its profitability through improved cost control and operational efficiency.

What else is there to say on the fundamentals of NYSE:CHE?

ChartMill assigns a Fundamental Rating to every stock. This score, ranging from 0 to 10, is updated daily and is determined by evaluating multiple fundamental indicators and properties.

CHE gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 116 industry peers in the Health Care Providers & Services industry. Both the health and profitability get an excellent rating, making CHE a very profitable company, without any liquidiy or solvency issues. While showing a medium growth rate, CHE is valued expensive at the moment.

For an up to date full fundamental analysis you can check the fundamental report of CHE

More ideas for quality investing can be found on ChartMill in our Caviar Cruise screen.

Disclaimer

This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.

Back

CHEMED CORP

NYSE:CHE (4/26/2024, 7:04:00 PM)

After market: 560.42 0 (0%)

560.42

-12.92 (-2.25%)

CHE News

News Image3 days ago - InvestorPlaceCHE Stock Earnings: Chemed Misses EPS, Misses Revenue for Q1 2024

CHE stock results show that Chemed missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

News Image3 days ago - BusinessInsiderCHE Stock Earnings: Chemed Misses EPS, Misses Revenue for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Chemed (NYSE:CHE) just reported results for the first quarter of 2024.Chemed re...

News Image4 days ago - Chemed CorporationChemed Reports First-Quarter 2024 Results
News Image11 days ago - Chemed CorporationVITAS Completes the Previously Announced Purchase of Assets of Covenant in Florida and Alabama
News Imagea month ago - Chemed CorporationChemed To Report First-Quarter 2024 Earnings April 24, Related Conference Call To Be Held On April 25
News Image2 months ago - Chemed CorporationVITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama
News Image2 months ago - Chemed CorporationChemed Corporation to Present at the Oppenheimer 34th Annual Healthcare Conference
News Image2 months ago - Seeking AlphaChemed Non-GAAP EPS of $6.60 beats by $0.35, revenue of $585.9M misses by $0.74M (NYSE:CHE)

Chemed reported Q4 2023 results, beating non-GAAP EPS estimates and missing revenue expectations.

News Image2 months ago - Chemed CorporationChemed Reports Fourth-Quarter 2023 Results
News Image2 months ago - Chemed CorporationChemed Corporation Declares Quarterly Dividend of 40 Cents
News Image2 months ago - Chemed CorporationChemed To Report Fourth-Quarter 2023 Earnings February 27, Related Conference Call To Be Held On February 28
News Image3 months ago - InvestorPlaceBarron’s Best Bets: 3 Under-the-Radar Stock Picks for Your Buy List

Finding under-the-radar stock picks involves looking in different places, including Barron’s annual roundtable discussion.

CHE Links
Follow us for more